Endovascular Today

IDE Approved for Sonorous Neurovascular’s B-SILENT 2 Pivotal Trial for BosStent to Treat Pulsatile Tinnitus

Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...
Endovascular Today

AngioDynamics Appoints Eric Honroth as President and Chief Executive Officer

AngioDynamics, Inc. announced the appointment of Eric Honroth as President, Chief Executive Officer, and a member of the company ...
Endovascular Today

VEITHsymposium Names Dr. Gustavo Oderich as Executive Director and Future Chairman

Frank J. Veith, MD, Chairman of the VEITHsymposium, announced that Gustavo S. Oderich, MD, will be assuming the role of the org ...
Endovascular Today

B. Braun Medical to Close Interventional Systems Division

B. Braun announced that it will wind down and close the B. Braun Interventional System Inc. (BIS) division. B. Braun stated that ...